Answer
NuvaRing’s oestrogens may reduce breast milk quantity and alter its composition, so use is generally not recommended until complete weaning; small amounts of contraceptive steroids or their metabolites may enter breast milk, but there is no evidence of adverse effects on infant health.
Sources for this answer
- NuvaringOrganon Pharma (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 23Document updated
Sources checked